mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
9e-09 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0004 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.003 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.006 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.008 |